GIVAUDAN N | 3,368.00 / +0.27% |
Date/Time | 08/12 / 17:30 |
Chg. / Chg.(%) | 9.00 / +0.27% |
Bid | 3,368.00 / 3 |
Ask | 3,419.00 / 1 |
Open | 3,342.00 |
Previous Close | 3,359.00 |
High | 3,407.00 |
Low | 3,342.00 |
Volume [CHF] | 84,581,058.00 |
Volume [Units] | 25,064 |
Price fixings | 3372 |
ISIN | CH0010645932 |
Security | GIVN |
Exchange | SIX Swiss Exchange |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 3,493.000 | ![]() |
|
SIX Swiss Ex.. | 3,368.00 | ![]() |
25,064 |
London Inter.. | 3,390.0 | ![]() |
10,654 |
Cboe Europe .. | 3,378.00 | ![]() |
6,136 |
Cboe Europe .. | 3,376.00 | ![]() |
2,856 |
Turquoise | 3,375.00 | ![]() |
787 |
Nasdaq Other.. | 3,566.0000 | 2 | |
EUREX | Options |
News
- Announcing the Innovators in Big Idea Ventures’ Latest Accelerator Cohorts
11/22/2021 / 15:00 - GlobeNewswire - France’s Avril invests in Big Idea Ventures
10/27/2021 / 14:00 - GlobeNewswire - Manus Bio and Givaudan achieve key milestones in sustainable ingredient development; launch planned for November
08/30/2021 / 16:38 - GlobeNewswire - Yunus Social Business and the Schwab Foundation for Social Entrepreneurship partner to support social intrapreneurs in their quest to transform corporations
06/09/2021 / 14:00 - GlobeNewswire - Big Idea Ventures Taking Applications for New Protein Fund’s Accelerator Program
03/18/2021 / 20:02 - GlobeNewswire